Clinical features |
Alarm symptoms suggestive of gastrointestinal malignancy |
|
Screening for Barrett's esophagus* |
Chronic GERD (at least 5 years of persistent symptoms) plus 3 of the following additional risk factors for Barrett's esophagus*:
|
Luminal abnormality on abdominal imaging of upper gastrointestinal tract |
GERD: gastroesophageal reflux disease.
* Professional guidelines provide different criteria for screening for Barrett's esophagus and are based predominantly on expert consensus. There is not randomized trial evidence that demonstrates a reduction in esophageal adenocarcinoma mortality with screening for Barrett's esophagus.